Background: B-type natriuretic peptide (BNP) levels in the first days after the onset of symptoms are predictive of short-term mortality in patients with acute coronary syndromes. Few data are available for BNP levels obtained on admission in patients (pts) with acute ST elevation myocardial infarction (STEMI). Methods: Blood samples for BNP determination were obtained on admission in 117 pts (mean age 58,4±10,7 years old) with STEMI. In a 15-minute period, BNP was measured by using simple bedside test for rapid quantification of BNP, before primary percutaneus coronary intervention (PCI). 30 days follow-up was performed. PCI was performed in all (100%) pts. Results: Mean for BNP was 171,8±218,2 pg/ml. Baseline level of BNP was higher among pts who died than among those who were alive at 30 days (median, 541,9±247,2pg/ml vs. 140,9±185,9 pg/ ml; p<0,001). Baseline BNP in subgroups by median level showed a significant increase in mortality: 1 (1%) in inframedian group (IMG) vs. 8 (13%) in supramedian group (SMG) (p<0,05). Baseline level of BNP in subgroups by Killip class on admission was higher among pts who died than among those who were alive at 30 days (Killip class I: median, 475,8± 280,6 pg/ml vs. 123,6±138,1 pg/ml p<0,05; Killip class II-IV: 257,1± 362,5 pg/ml vs. 624,5± 203,9 pg/ml, p=0,01). After adjustment for independent predictors of risk of death, the odds ratio for death at 30 days in SMG was 13,6 (95% confidence interval, 1.1 to 182.7). There was no difference in subgroups by median BNP in TIMI 3 flow grade before PCI (7% vs. 7%; p=NS). TIMI 3 after PCI was more often seen in pts in IMG vs. SMG (90% vs. 72%, p=0,01). BNP was higher among pts with TIMI 0, 1 or 2 after PCI than among pts with TIMI 3 after PCI (328,3±332,8 pg/ml vs. 151,32±196,7 pg/ml; p<0,01). BNP remained independent predictor for TIMI 0, 1 or 2 after PCI (odds ratio in SMG was 3,5 (95% confidence interval 1,2 to 10,8). Conclusion: BNP levels obtained on admission are powerful, independent indicator of short-term mortality and angiographic success after PCI in pts with STEMI. Rapid tests for BNP assay seem to be new tool in risk stratification of pts with STEMI.
